NanoViricides Stock Price

0.04 (0.7%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NanoViricides Inc NNVC AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 0.7% 5.74 20:00:00
Close Price Low Price High Price Open Price Previous Close
5.74 5.58 5.78 5.70 5.70
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
856 131,187 $ 5.69 $ 746,562 1,819,557 0.16045 - 19.80
Last Trade Time Type Quantity Stock Price Currency
20:00:00 1,130 $ 5.74 USD

NanoViricides Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 61.12M 10.65M 9.54M $ - $ - -2.39 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
672.98k $ - 0.00% - -

more financials information »

NanoViricides News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NNVC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.136.505.505.95401,101-0.39-6.36%
1 Month7.097.655.506.51669,198-1.35-19.04%
3 Months7.6010.885.507.841,183,515-1.86-24.47%
6 Months7.1114.374.608.311,473,010-1.37-19.27%
1 Year0.2519.800.160459.381,546,8505.492,196.0%
3 Years1.2519.800.160457.90628,8944.49359.2%
5 Years1.3219.800.160457.17428,2384.42334.85%

NanoViricides Description

Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.